Mark Fishman
Mark Fishman | |
|---|---|
| Citizenship | United States |
| Alma mater | Yale College, Harvard Medical School |
| Known for | pioneering Zebrafish research in cardiology |
| Awards | Institute of Medicine member, Fellow of the American Academy of Arts and Sciences |
| Scientific career | |
| Fields | Medicine, Cardiology |
| Institutions | Novartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School |
Mark Fishman is an American cardiologist, a professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service service at the Massachusetts General Hospital for patients with complex medical disorders.[1] A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),[2] the main research arm of Novartis Pharmaceuticals.[3]
Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[4] He is the author of over 100 publications[5] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[6][7][8]
Education
[edit]- B.A. Yale College, 1972
- M.D. Harvard Medical School, 1976
Career
[edit]He was previously a professor of medicine at Harvard Medical School, chief of cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.[9]
After being the head of Novartis for 13 years, he decided to retire in 2016[10] and became professor at Harvard and Chief at MGH[1]
References
[edit]- ^ a b "Mark C. Fishman, M.D." Harvard Department Of Stem Cell And Regenerative Biology. Retrieved Oct 19, 2022.
- ^ "Novartis People". Archived from the original on 2015-06-01. Retrieved 2009-10-20.
- ^ "Novartis Corporate Fact Sheet". Archived from the original on 2011-02-02. Retrieved 2009-10-20.
- ^ "PRdomain.com | Novartis| Novartis steps up US research investment, opening Cambridge, Massachusetts Biomedical Research Center". Archived from the original on 2011-06-16. Retrieved 2009-10-20.
- ^ http://www.pubmed.gov 183 results as of 20 Oct 2009
- ^ Barut, Bruce A.; Zon, Leonard I. (2000). "Realizing the potential of zebrafish as a model for human disease". Physiological Genomics. 2 (2): 49–51. doi:10.1152/physiolgenomics.2000.2.2.49. PMID 11015581. S2CID 12510521.
- ^ "Fishman profile, Forbes.com". Jan 2002. Archived from the original on 2009-04-03.
- ^ "Fishman biographical sketch" (PDF). Archived from the original (PDF) on 2011-07-25. Retrieved 2009-10-20.
- ^ "Media" (PDF).
- ^ Damian Garde (24 September 2015). "Novartis' top scientist is stepping down after 13 years, making way for a Harvard luminary". Fierce Biotech. Retrieved 13 December 2016.
External links
[edit]- Novartis Institutes for BioMedical Research Official Homepage
- Novartis Institutes for BioMedical Research Official Homepage
- Mark Fishman on changing the grammar of drug discovery
| International | |
|---|---|
| National | |
| Other | |
- Living people
- American medical researchers
- American cardiologists
- Businesspeople in the pharmaceutical industry
- American business executives
- Yale College alumni
- Harvard Medical School alumni
- Harvard Medical School faculty
- Fellows of the American College of Cardiology
- Members of the National Academy of Medicine